COMMUNIQUÉS West-GlobeNewswire

Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older
26/02/2018
DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]
Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics for Subcutaneous Factor IX Product CB 2679d
26/02/2018
Catalyst plans to initiate a Phase 2b study of CB 2679d in Q3 2018 SOUTH SAN FRANCISCO, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company [...]
Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference
26/02/2018
CAMBRIDGE, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
K2M and International Spine Study Group Foundation Collaborate to Advance Data Management Using BACS®
26/02/2018
LEESBURG, Va., Feb. 26, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Athenex, Inc. to Report Fourth Quarter and Full Year 2017 Earnings Results on March 26, 2018
26/02/2018
BUFFALO, N.Y., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Profound Medical to Participate in 2018 BTIG Healthcare Conference
26/02/2018
TORONTO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the precision of real-time MR [...]
ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial
26/02/2018
-------------------------------------------------------------------------------------------------- Gencaro Demonstrates Comparable Efficacy to Active Control and Trend for Potential Gencaro Superiority in US Patient [...]
Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results
26/02/2018
– Phase 3 VISION Trial Design Finalized for 177 Lu-PSMA-617 Following Successful End of Phase 2 Meeting with the FDA – – Announced Agreement for Clinical Supply of No-Carrier-Added Lutetium with ITM – – Added [...]
Clearside Biomedical Announces Organizational Changes Designed to Support Transition to a Commercial-Stage Company
26/02/2018
ALPHARETTA, Ga., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today [...]
Radient Technologies Inc. Announces Master Services Agreement with Medical Cannabis Supplier Bonify
26/02/2018
EDMONTON, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc . ("Radient" or the “Company”) (TSX-V: RTI ) announces the signing of a Master Services Agreement (the “Agreement”) to produce a variety of [...]
Extendicare Announces Agreement to Acquire Lynde Creek Retirement Community
26/02/2018
MARKHAM, Ontario, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced that it has entered into a definitive agreement to acquire the Lynde Creek Retirement [...]
Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial
26/02/2018
WEST LAFAYETTE, Ind. and MUNICH, Germany, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), and ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced a [...]
Hemostemix Signs License Agreement with Aspire Health Science
26/02/2018
CALGARY, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc . (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased to announce it has finalized the terms of a license agreement (the “ License [...]
PotNetwork Holding’s Diamond CBD Books Over $270,000 in Sales at CHAMPS Winter Show at Las Vegas Convention Center
26/02/2018
FT. LAUDERDALE, Fla., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holding Inc. (OTC Pink:POTN ) is pleased to announce that its wholly owned subsidiary, Diamond CBD , Inc., which exhibited its 2018 [...]
Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Results
26/02/2018
DUBLIN, Ireland, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), today announced it will report its fourth quarter and full year 2017 financial results on Thursday, March 8, 2018, before [...]
Strongbridge Biopharma plc Announces Underwriters’ Partial Exercise of Option to Purchase Additional Shares
26/02/2018
DUBLIN, Ireland and TREVOSE, Penn. , Feb. 26, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP ) (the “Company”) today announced that the underwriters of its previously announced underwritten public [...]
SAVE THE DATE: Ninth Annual "Mardi Gras for Autism" Expects 4,000 Attendees at Fullerton Cares Event Raising Awareness for Autism – 4/7/2018
26/02/2018
FULLERTON, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- To support autism charities and special education, Fullerton Cares’ ninth annual FREE family carnival benefit, “Mardi Gras for Autism” will be held outside Bourbon [...]
The Joint Corp. to Present at the 30th Annual ROTH Conference
26/02/2018
SCOTTSDALE, Ariz., Feb. 26, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will present at the 30 th Annual ROTH Conference on [...]
ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
26/02/2018
The WHO considers infertility a global public health issue affecting 186 million people, and only 1 in 4 ART treatments results in childbirth Geneva, Switzerland and Boston, MA - 26 February, 2018 - ObsEva SA (NASDAQ: [...]

Pages